URGES-BIOSIMILAR DRUGS
Summary
Urges the Congress of the United States to help ensure that any new legislation allowing for approval of biosimilar drugs includes provisions to ensure that the public health is protected by adequate testing of biosimilar products and physician control over which treatments their patients receive, and that the legislation preserves the ability to create innovative and important new biotechnology therapies.
Bill status
failed
1 of 4 stages cleared
Introduction
Mar 2009
Committee Review
Floor Vote
Governor
Introduced Mar 10, 2009
Last action Jan 11, 2011
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
3
Jan 11, 2011
House · Failed
Session Sine Die
Dec 1, 2009
House · Referred to committee
Rule 19(b) / Re-referred to Rules Committee
Mar 16, 2009
House · Referred to committee
Assigned to Bio-Technology Committee
Mar 11, 2009
House · Referred to committee
Referred to Rules Committee
0 primary · 1 co-sponsor
Sponsors
Role
Legislator
Party
State
District
Co
Maria Antonia Berrios
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HJR 35
Scope: IL
Hi! I can help you understand HJR 35. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline